A B S T R A C T A peptide of approximately 300-400 daltons exhibiting in vitro chemotactic activity for human polymorphonuclear (PMN) leukocytes, with a preference for the eosinophil series, was isolated from extracts of anaplastic lung carcinomas of the large squamous cell type obtained from three patients with marked peripheral blood hypereosinophilia and eosinophilic infiltration of the tumors and surrouniding normal pulmonary tissues. This chemotactic factor was termed ECF-LSC (eosiinophil chemotactic factor of lung squanmous cell carcinomiia). ECF-LSC appeared in the urine of two of the patients in increasing quantities late in the course of their disease and was also elaborated by long-term cultures of dispersed tumor cells from the same two patients. Three anaplastic large cell bronchogenic carciinomas which were not associated with tumor tissue or peripheral blood eosinophilia, a bronchogenic adeinocarcinonma from a patient with only peripheral eosinophilia, and a renal cell carcinoma metastatic to the lungs and associated with transient pleural tissue and fluid eosinophilia were all devoid of ECF-LSC. ECF-LSC from tumor tissue extracts, urine, and tumor cell culture medium was comparable to the mast cell-associated tetrapeptides ofthe eosinophil chemotactic factor ofanaphylaxis (ECF-A) in size, but eluted from Dowex-1 at pH 5.0-3.5 in contrast to the more acidic ECF-A tetrapeptides which eluted at pH 3.2-2.2. ECF-LSC, like the tetrapeptides of ECF-A, had a secondary chemotactic activity for neutrophil PMN leukocytes, but not 
INTRODUCTION
The appearance of peripheral blood eosinophilia inl association with ac malignant tumor is an uncommoni ocecurrence ancd tusually signifies either the development of metastatic lesions or a tissue response to irradiationi of the tumllor (1) (2) (3) . In a few cases, however, peripheral eosinophilia has resolved upon removal of' the neoplasnm which implies an etiologic relationship to the tumor (1, 4) . In one patient with an anaplastic bronchogenic carcinoma associated with both peripheral eosinophilia and eosinophilic infiltration of the tumor, a low molecular weight peptide chemotactic for eosinophils was extracted from tumor tisstue (5) . The ttumor-derived eosinophil chemotactic factor (5) was comparable to the tetrapeptides ofthe mast cell-derived eosinophil chemotactic factor of anaphylaxis (ECF-A)1 (6) with respect to size, functioni, and susceptibility to inactivation 1by digestioni with subtilisini. The Histamine levels in tumilor tisstue anid cell extracts and portions of chromatography fraction s were measiured by a radioenzvme assay (8 (9) . Ctultuires were incubated at 37C ini humiiiiclified 5% CO2-.95% air, and medium was harvested and renewed once weeklv in flasks and twice a week in dishes. 20 (10) . Aftera30-min incubation at370C, the leukocvte-rich plasmla was transferred to fresh tubes and cenitrifuged to obtain a cell pellet which was resuspended in 0.84% NH4CI for 2 min at room temperature to lyse residual erthrocytes. The mixed leukocvtes were washed and suspended in Haniks' solution made 0.4 g/100 ml in ovalbumin and 0.01 NI in Tris-HCl, pH 7.4 (Hanks'-ovalbumiii). The suspensioi.s of leuikocv-tes froml niormal subjects were centrifuged on Ficoll-Hypaque ctishionis to obtain purified neutrophils and m10ononuticlear leukocvtes (11) and the stuspenisions of leukocvtes froml hvpereosinophilic donors were uised directly in chemotactic assays.
ChemlotaXxis was assessed by a miiodificationi (10, 12) of the Boyvden micropore filter technii(lue (13) . 1 ml ofcell suspension containinlg 2.0±0.5 x 106 eosiniophils or neutrophils or 3.5+0.3 x 10" mononiuclear leukocytes was pipetted into the top comiipartmiienit of cach polystyrene disposable chemiiotactic chamber (Adaps, Inc., Dedhamii, Mass.); a 3-,um pore filter (Millipore Corp., Bedford, Mass.) separated the leukocytes from' the 1 ml of chemotactic stimlulus in the lower compartment. After a 2.5-h incubation at 37°C, the filters were removed, processed, and stainied by a procedure designed to differentiate eosinophils froml neutrophils (10, 12) , and the leukocytes were microscopically eniumilerated in 10 high power fields at a fixed level of 70-90 ,Il from the cell source. This distance was selected to achieve background counts of two-eight leukocytps per high power field (hpf) in the absence of a chemotactic stimulus. Cells were then counted without knowledge of the protocol in 5 hpf from each of duplicate filters, and these values expressed as the mean net leukocytes per hpf by correctioni for spontaneous migrationi in additional control chambers. 
RESULTS
Four patients with bronchogeniic carcinoma and one patient with renal cell carcinoma metastatic to the lungs exhibited local and(or) peripheral blood eosinophilia as a manifestation of their disease ( Table I) . Three of the patients (Table I, 3,000 daltons, which was about equally chemotactic for eosinophils and neutrophils. Tumor extracts from patients 1 to 3 exhibited a low molecular weight peak, attracting more than 10 net eosinophils/hpf per 100 gl of each fraction, which filtered in the same region as the radiolabeled valyl-tetrapeptide of ECF-A and was chemotactic for PMN leukocytes, with a preference for eosinophils (Fig. 1) . Crude extracts from lymph node tumor metastases, concentrated samples of a 24-h urine collection, and tumor cell culture fluid of patient 2 were filtered on Sephadex G-25 columns in an identical manner (Fig. 2) . In the urine and culture fluid samples, the high molecular weight chemotactic activities were less prominent relative to the activities in the intermediate and low molecular weight regions, both of which exhibited preferential chemotactic activity for eosinophils over neutrophils. Because the low molecular weight peak of eosinophilotactic activity was present in samples from diverse sources of the patients with squamous cell lung tumors, and most closely resembled ECF-A tetrapeptides in size and preferential chemotactic activity for eosinophils compared with neutrophils and monocytes, it was selected for further analysis.
To provide a quantitative estimate of the low molecular weight eosinophilotactic activity from diverse sources, the fractions from 70-84% bed volume obtained from the tumor, urine, and culture fluid from patient 2 (Fig. 2) In the three patients with a squamous cell bronchogenic carcinoma, quaintitation of the low molecular weight ECF in biopsies and autopsy samples of tumor (Table II, (Table I ). (Table II) . The aniaplas- tic large cell tumors of the three patients who lacked eosiniophilia cointainied low moleciular weight ECF in (quanitities of 0.04, 0.12 and 0.18 niet eosiinoplhils/hpf per mg in extracts of 0.6-3 g of tumzor tissuie. Low molecular weight ECF activity was absent from the pulmonary imietastases of patienit 5 anid was less than 0.1 net eosiniophil/hpf'per mg in extracts of 2-4 g of three renial cell carcinomnas alild two colon ic carciniomlas friom patients lackinig eosiniophilia.
Partial purificationi anid characterizationi of tum70or-derived low2 molecular wceight ECF. The low molectular weight ECF activity fromii extracts of normiial Ilung alild ttumor tissue antld from conicenitrates of tumor cell ctultture mlediai, turinie anid pleuiral fluiid were applied to Dowex-1 in 0.1 MI pyridine and(c eltitedl with a liniear pvridineformiiic acid gracdient. A broad peak of ECF activity xw,,as dletected in the pH rainge of 5.0 to 3.5 for extracts f'rom ttumors of patienits 2 a<ndl 3 ( Fig. 3) acnd( for cell cuiltuire suiperniates fiomn the samiie tumiiiors aindl uirinie from the samne patients (not shown). As the low imiolecuilar weiglht chemlotactic f'actors dlerived froml lunig sq(uItiamouis cell carcii omiias clearly differed in clharge from the ECF-A tetrapeptides of comparal)le size and eosintophil specificity, the tumiior derive(d imiaterial was designiatedl ECF-LSC (eosiniophil chemiiotactic factor of' luniig s(quamiious cell carciniomiia). In contrast, the lo0NT molecular weight peak of ECF activity in the pleural fluid from patient 5 an(d in ain extract of a nonitumllorotis humlllan lunig surgical specimene obtained fromii a patienit with bronchiectasis (niormlal lunig extract) appeared in the mlore aciidic rainge ofpH 3.2 to 2.2, clharacteristic ofthe elution positioni of the preformed ECF-A tetrapeptides (6) . Pools of low%-molecular weight ECF from Sephadex G-25 filtriationi of 1-5 g of ttunmor from patienit 4 an( 0.6-3 g each of tle tlhree anaiiiplastic large cell Ilung tmt)iiors unassociated xvith eosinophilia, and the five nonluniiig tumiiiors (lid ntot conitaini detectable activity after DowN,ex-1 chromatography.
Highi voltage papei-electroplhoresis (Fig. 4) eosiniophil chemiiotactic activity that migratedl anodally at pH 5.6 at approximnately half the rate of the ECF-A tetrapeptide, Val-Glv-Ser-Glu, which is consistent with the less acidic nature of ECF-LSC. The low molecular weight ECF activity from patient 3 derived from both tissue extracts (Fig. 3) and cell culture supernate (Fig. 4) contained not only ECF-LSC, but also additional components exhibitinig a degree of acidity comparable to the ECF-A tetrapeptides and possibly even more acid material found between 32 and 38 cm (Fig. 4) .
Portions ofthe pooled Dowex-l peaks of low molecular weight ECF were incubated for 6 hr at 37°C with 10 ,ug of subtilisin or trypsin per four maximal chemotactic doses of each principle. Subtilisin digestion inactivated the Dowex-I pool of ECF-LSC from patient 2 tumor extract by 86% and from patient 3 tumor extract by 79% and inactivated the more acidic ECF from patient 5 pleural fluid by 83%; similar treatment with trypsin gave less than 20% inactivation of any of the samples. Subtilisin had previously been shown to inactivate the low molecular weight ECF of normal lung and of the ttumor of patient 1 (5, 6). Thus both ECF-LSC from patients 2 and 3 and the more acidic ECF of patient 5 were comparable to the ECF-A tetrapeptides in terms of their susceptibility to proteolytic inactivation. The leukocyte chemotactic preference of ECF-LSC at various stages of purification was examined in parallel with previously defined chemotactic stimuli by employing a range of concentrations of each factor and puirified populations of target leukocytes. The chemotactic activities for neutrophils, eosinophils and nmonocytes are compared in Table III utilizing that concentration of each stimulus which achieved a neutrophil response of 15-25 net cells/hpf. The ratio of eosinophil to neutrophil chemotactic activity for ECF-LSC in the initial low molecular weight pool from Sephadex G-25 was 1.5 and increased to nearly three after Dowex-1 chromatography and high voltage electrophoresis on paper. The degree of eosinophil preference exhibited by ECF-LSC was similar to that for both the valyl tetrapeptide of ECF-A and the lipid factor HETE (Table III) . None of these factors had appreciable chemotactic activity for mononuclear leukocytes. In contrast, C5 fragment was about equally chemotactic for eosinophils, monocytes, and neutrophils while kallikrein was preferentially chemotactic for neutrophils.
In vitro assessment of the capacity of the eosinophils of the patients to respond to C5 fragment and the low molecular weight ECF of their own tumors revealed a markedly depressed response for patient 2 and the loss of responsiveness for patient 3. These patienits exhibited high levels of ECF-LSC in extracts of tumor and uirine. In patient 3, simultaneous studies of his own eosinophils and low molecular weight ECF suggested a relationship of the decreased chemotactic responsiveness to high levels of urinary excretion of ECF-LSC. The eosinophil defect in patient 2 was profound and included not only chemotaxis, but also a poor response to sodium ascorbate which enhances random migratioin 776 E. J. Goetzl FIGURE 4 High voltage paper electrophoresis of low molecular weight ECF in tumor cell culture supernatant media. The Sephadex G-25 low molecular weight peak of eosinophil chemotactic activity from the equivalent of 5 ml of pooled culture medium of patienits 2 and 3, and 20 nmol of purified synthetic Val-Gly-Ser-Glu were subjected to electrophoresis. 1/10 of the eluate from each 1-cm wide paper strip was assessed in duplicate for chemotactic activity employing eosinophils from a donor with 32% peripheral blood eosinophilia. * The purified leukocyte suspensions contained: neutrophils, 95-98% neutrophils and 2-5% mononuclear leukocytes; eosinophils, 42-84% eosinophils, 5-23% neutrophils, and 11-34% mononuclear leukocytes; mononuclear leukocytes, 69-77% lymphocytes, 18-24% monocytes, and 3-6% neutrophils. Results shown are mean+ 1 SD net leukocytes/hpf for three preparations of each cell type from separate donors utilizing the same source of each stimulus. Background counts in the absence of stimuli averaged: neutrophils, 4; eosinophils, 9; mononuclear leukocytes, 3. $ Kallikrein from human plasma (18) yielded 1.1 ,ug bradykinin/ml from 0.2 ml of heat-inactivated plasma. § C5 fragment was derived from trypsin treatment of 2.5 ,ug equivalent of C5/ml. "HETE concentration was 10 ,ug/ml (19) . ¶ Val-Gly-Ser-Glu concentration was 0.1 uM.
** 1/10 of the pool of low molecular weight ECF from tumor extract of patient 2 ( Fig. 2) was employed as the stimulus in each chemotactic chamber.
t I 1/10 of a pool of fractions 6 and 7 for patient 3 ( Fig. 3) was the stimulus. § § 1/10 of a pool of eluates from paper strips 8-12 cm from the origin for patient 2 (Fig. 4) was the stimulus.
of normal eosinophils by greater than 100% (15, 23) . The Dowex-I fraction of ECF-LSC obtained from an extract of tumor from patient 3 was compared with the more acidic fraction from normal lunig and with synthetic ECF-A tetrapeptide for their capacity to deactivate eosinophils in vitro (Fig. 5) . The concenitrations of chemotactic factors were adjusted to those eliciting comparable eosinophil chemotactic responses. The Dowex-I fraction from the tumilor extract and from normal lung gave 40-50% deactivation by 5 min and 80% deactivation by 20 min; the valyltetrapeptide produced 80% deactivationi by 5 min and complete chemotactic unresponsiveness by 10 mIi. DISCUSSION Anaplastic squamous cell lung carcinomas from three patients with profound bone marrow, peripheral blood, and tumor eosinophilia contained a low molecular weight factor chemotactic for human PMIN leukocytes, with a preference for eosinophils (Tables I and II) . This factor could be distinguished on the basis of charge from the ECF-A tetrapeptides previously recognized as constituents of normal human lung tissue (6, (24) (25) (26) . The low molecular weight eosinophilotactic activity was lacking in extracts of an adenocarcinoma of the lung of a patient with mild peripheral blood eosinophilia, but without eosinophil infiltration of the tumor, a renal cell carciiionoa meta'static to the lung which elicited a local eosinophilia only in the pleural space (Tables I  and II PRE/NCU8AT/ON INTERVAL (mini FIGURE 5 Eosinophil chemotactic deactivation by partially purified low molecular weight ECF from tumor and normal lung and by tetrapeptide. Unpurified eosinophils, from a patient exhibiting 53% eosinophilia, were preincubated for varying time periods with factors diluted to achieve chemotactic activities of 16 net eosinophils/hpf for Dowex-1 fraction 6 of patient 3 (Fig. 3) , 14 for Dowex-1 fraction 10 oflung tissue (Fig.  3) , and 10 for lOnM valyl-tetrapeptide. Eosinophils were then washed and placed in chambers containing a twofold higher level of Dowex-I fraction 6 eosinophilia including three large cell aniaplastic lung carciinomas, three renal cell tumors, and two colonic carcinomas. Furthermore, monolayer cultures of dispersed tumor cells from two of the patienits with squamous cell lung carcinioma secreted low molecular weight eosinophilotactic activity. Extracts from each of the five tumors from the patients with eosiinophilia also demonstrated high molecular weight neutrophil chemotactic activities and intermediate molecular weight chemotactic activities which were capable of attracting eosinophils and neutrophils (Fig. 1) . These chemotactic activities were also present in the supernatant media of tumilor cell cultures assayed over a period of approximately 10 mo (Fig. 2, Table II ). Neither the intermediate molecular weight activities for eosinophils and neutrophils nor the high molecular weight neutrophil activities from the tumor extracts or the culture supernates were fturther characterized because factors of comparable size extracted from normal human lung or purified rat mast cells have not l)een sufficiently defined to permit a comparisoni on a l)asis other thani size (27) . In contrast, the peptide components of ECF-A have been structurally definied as being composed of at least two acidic tetrapeptides (6), thereby affording acn opportunity to comiipare the physical and functional characteristics of' the low molecular weight material elaborated by the squamous cell lung carcinomas with these acidic tetrapeptides.
The initial suggestion that tumor-derived low molecular weight ECF did not come from mast cells was based on the relative lack oftumor tissue histamine as compared to the quantity of eosinophil cheimiotactic activity (5). This point is now substantiated by the finding that the conicentration of low molecular weight ECF in extracts of the squamous cell carcinomas was 2 to 35 times that of normal lung tissue while the histamine contenit of the tumor tissues was only 1/5 to less that 1/100 that of nontumor lung tissue (Table II) . More critical was the long-term elaboration by dispersed tumor cell cultures of an eosinophil chemotactic peptide indistiniguishable from the activity in the orignial tumor extracts by size (Fig. 2) , charge (Fig. 4) , and susceptibility to inactivation by subtilisin. The low molecular weight ECF activity extracted from the squamous cell lung carcinomas eluted from Dowex-1 in a peak in the less acidic region at pH 5.0-3.5, compared to the low molecular weight material extracted from normal human lung and from the pleural fluid of patient 5, which eluted at pH 3.2-2.2 in the same position as the ECF-A tetrapeptides (6, 27; Fig. 3 ). The migration in high voltage paper electrophoresis of the low molecular weight ECF activity from the squamous cell carcinomas again confirmed that it is less anionic than the tetrapeptides of ECF-A, although in the case of' patienit 3, but not patient 2, there were substantial quantities of more acidic low molecular weight ECF activities as well (Figs. 3 and 4) . The low molecular weight ECF activity present in large aimlouints in the squamous cell lung carcinoma and elaborated by cultures of dispersed tumor cells is designiated eosinophil chemotactic factor of lung squamous cell carcinoma (ECF-LSC) to distinguish it from the more acidic tetrapeptides derived from mast cells, where the activities appear to be associated with the metachromatic granules (26, 27) . The designation ECF-LSC is arbitrarily descriptive so as to denote the source of this newly recognized ECF, but does not eliminate the possibility of other derivations.
ECF-LSC attracted eosiniophils and neutrophils in a dose-response fashion. The preference of ECF-LSC for eosinophils compared to neutrophils and the relative lack of effect for monocytes was observed at each of the stages of purification. The degree of preference for eosinophils was equal to or greater than that of the synthetic tetrapeptide, Val-Gly-Ser-Glu, and the highlyv purified lipid HETE in the same three experiments (Table III) . The eosinophil response required a concentration gradient indicating that ECF-LSC is a chemotactic factor. Furthermore, as is characteristic of other chemotactic factors including the ECF-A tetrapeptides (6, (14) (15) (16) , pretreatment of eosinophils with ECF-LSC depressed their subsequent response to the homologous stimulus (Fig. 5) , a phenomenon termed functional deactivation. The markedly depressed response of the eosinophils of patient 2 to C5 fragmeint or autologous ECF-LSC and the eventual loss of the chemotactic response of eosinophils from patient 3 are tentatively attributed to in vivo chemotactic deactivation.
Patients 2 and 3 had heterogenous polymorphonuclear leukocyte chemotactic activity in the urine, and Sephadex G-25 filtration ofurine concentrates showed a prominent low molecular weight peak which was comparable in size and charge to ECF-LSC and also exhibited preferential activity for eosinophils (Fig. 2, Table II ).
ECF-LSC increased in the urine of both patients with progression of tumor growth, but was never detected in plasma or serum. The quantity of ECF-LSC excreted per 24 h reached a level eqjuivalent to that extractable from 0.5 to 2.0 g oftumor tissue. Such excretion rates are compatible either with localized tumor necrosis or elaboration by viable tissue in a manner comparable to that of cultured cells. Although multiple chemotactic factors of differing leukocyte specificities were elaborated by the tumors, the small size of ECF-LSC may have facilitated access of high concentrations to eosinophils in the peripheral blood and possibly in the bone marrow stores, as manifested by the presence or development of apparent in vivo chemotactic deactivation. Thus ECF-LSC or a separate tumor-derived eosinopoietic factor or both acting in concert could have stimulated production of eosinophils and their release into the cireculatioin. The previously recognized capacity of malignaint lung ttumors to produce peptides normally, secreted by other organs (28) (29) (30) (31) (32) , suggests that ECF-LSC may be presenit in unldetectable aimlouInts in certaini as vet uindeterminiied norimlal tissues.
